Stonebridge Financial Planning Group’s Thermo Fisher Scientific TMO Stock Holding History

Stonebridge Financial Planning Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$57K	–	342
2021 Q4	$57K	Hold	100	–	–	0.03%	208
2021 Q3	$64K	Hold	100	–	–	0.03%	198
2021 Q2	$51K	Hold	100	–	–	0.03%	212
2021 Q1	$48K	Hold	100	–	–	0.03%	218
2020 Q4	$47K	Hold	100	–	–	0.03%	202
2020 Q3	$47K	Hold	100	–	–	0.03%	195
2020 Q2	$37K	Hold	100	–	–	0.03%	204
2020 Q1	$31K	Hold	100	–	–	0.03%	204
2019 Q4	$32K	Buy	+100	New	+$30.3K	0.03%	199

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonebridge Financial Planning Group's TMO Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 100 shares — an estimated $57K sold.

Stonebridge Financial Planning Group first reported a position in TMO in Q4 2019 and held it in 9 quarters. The position peaked at $64K in Q3 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Stonebridge Financial Planning Group reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
Stonebridge Financial Planning Group sold 100 Thermo Fisher Scientific shares in Q1 2022, an estimated $57K.
Stonebridge Financial Planning Group first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 9 quarters.
Stonebridge Financial Planning Group's Thermo Fisher Scientific position peaked at $64K in Q3 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.